Navigation Links
8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds
Date:10/5/2009

factors, including high total triglycerides as well as low HDL cholesterol as compared to total cholesterol and triglycerides.

"This study was initiated based on the compelling results from pre-clinical studies and an initial clinical trial," said lead researcher Michael H. Davidson, MD. "We are excited with the outcome of this larger study because while we did not see a reduction in the group as a whole, there is an indication that the rate of CIMT progression slowed in subgroups of patients characterized by more rapid CIMT progression."

In conclusion, the authors call for these preliminary findings to be investigated in future studies, because "consumption of pomegranate juice is very safe; thus demonstration of a benefit on atherosclerotic disease progression, even in a subset of the population, would have important public health implications."

The publication of this study is the most recent in series of studies evaluating the potential benefits of POM Wonderful 100% Pomegranate Juice on human health. In 1998 POM Wonderful initiated a world class medical research program to investigate the Wonderful variety pomegranate. To date, POM Wonderful has funded $32 million in research, which has involved a number of top scientists from leading universities around the world, including a Nobel Laureate. So far, 48 total studies have been published in peer-review journals. Primary research areas have included the prostate and cardiovascular, among others.

Source Cited:

M. Davidson et al., Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness in Men and Women at Moderate Risk for Coronary Heart Disease, American Journal of Cardiology (2009)

About POM Wonderful

POM Wonderful is the largest producer of California Wonderful pomegranates and the company exclusively grows and sells this variety. POM Wonderful's pomegranates grow in central California, in the su
'/>"/>

SOURCE POM Wonderful
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--TheBlackAIDSInstituterecentlyheldBoardofDirec... ,, ThenewBoardMembersareahighlydiversegroupofl...vernmenthealthprograms,editorial,andbusinessentrep...albackgroundsincludingbothheterosexualandgayBlackm...tingmultipleagegroups. ,, (Photo: http://www.ne...
(Date:11/25/2009)...o were treated with cisplatin-based chemotherapy h...l side effects and Raynaud-like phenomena, than me...g to a new study published online November 25 in t... Marianne Brydy, M.D., of the Department of Oncolo...ay, and colleagues conducted a cross-sectional stu...
(Date:11/25/2009)...simple question has been the focus of intense rese...lates High Blood Pressure in Mice & Men, Does str... has been the focus of intense research for many y...ablished a link between a novel gene, phosducin, a...s well as humans. The studies were directed by sci...
(Date:11/25/2009)...tment clinics to resume Monday, Nov. 30 , ...09 -- Centegra Health System is continuing to offe...ur Centegra Primary Care (CPC) vaccination clinics...e clinics are at CPC sites in Huntley, Woodstock, ...ws: ,   From 4:30 to 7:30 p.m. Tuesday...
(Date:11/25/2009)...trouble with the H1N1 vaccine, , , WEDN...1 swine flu pandemic may be driving a recent spike... U.S. health official said Wednesday. , "We are...ions around the country," Dr. Anne Schuchat, direc...spiratory Diseases at the U.S. Centers for Disease...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
... Sir Speedy Whittier one of the nation,s p...tions, and Zultys Inc. a leader in corporate Uni...advanced Unified Communications deployment that re... solution provided the features and functions that...
...LA,s Jonsson Comprehensive Cancer Center have deve...ew genes that can predict a predisposition to canc... Radiation Research , was done in yeast and mamma... on that genetic instability. If they can uncover ...
...March 25 Health Robotics today announced,the earl...ATION Profile,option with a presentation [P13] at ...logies Conference and Exhibition (DUPHAT), http://...at no additional cost] was originally,scheduled to...
...t benefits from cutting-edge treatment , , MACO...lled to welcome her twin sons Dawson and Dakota in...to concern when she noticed that over time Dawson,...osition in an infant carrier or crib. , , Ter...
...ch 25 Dr. Bindeshwar Pathak, founder of,Sulabh Sa...9 Stockholm Water,Prize Laureate. , To view th...ww.prnewswire.com/mnr/siwi/37595/ , As the Fo...o improve public health, advance social progress, ...
... Effect Ensures Maximum Value from Pharmacy Progra... Gorman Health Group announced a joint offering to...mprehensive drug benefit oversight. Gorman Health...ce and financial services to offer a comprehensive...
Other Medicine News:Health News:Sir Speedy Whittier and Zultys Announce Advanced Unified Communications Deployment -- Zultys Solution Boosts Responsiveness, Cuts Costs 2Health News:Sir Speedy Whittier and Zultys Announce Advanced Unified Communications Deployment -- Zultys Solution Boosts Responsiveness, Cuts Costs 3Health News:Sir Speedy Whittier and Zultys Announce Advanced Unified Communications Deployment -- Zultys Solution Boosts Responsiveness, Cuts Costs 4Health News:Discovery may result in new test to determine predisposition to cancer 2Health News:Discovery may result in new test to determine predisposition to cancer 3Health News:Health Robotics Announces the Early Release of the i.v.STATION(TM) Profile Option and DUPHAT Presentation 2Health News:Health Robotics Announces the Early Release of the i.v.STATION(TM) Profile Option and DUPHAT Presentation 3Health News:STARscanner, STARband Cranial Helmets Making a Difference in the Lives of Children 2Health News:STARscanner, STARband Cranial Helmets Making a Difference in the Lives of Children 3Health News:Indian Sanitation Innovator and Social Reformer Awarded 2009 Stockholm Water Prize 2Health News:TRICAST, Inc. and Gorman Health Group Form Partnership to Fully Support Medicare Part D Oversight 2Health News:TRICAST, Inc. and Gorman Health Group Form Partnership to Fully Support Medicare Part D Oversight 3
(Date:11/25/2009)...PARK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTe...efoamthatstopsseverebleeding,wonfirstprizeand$10,0...lSecurityChallenge2009,companyofficialsannouncetod...theworld,Remedium,steampitchedtheirinventionattheG...usiness. ,, Remedium( www.remediumtechnologies....
(Date:11/25/2009)...China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyO...)(Nasdaq: CSKI ),a,leadingfullyintegratedpharmaceu...rdrugsinthePeople,sRepublicofChina("PRC"),today,an...nalInstitutefor,theControlofPharmaceuticalandBiolo...oducts:itsDiagnosticKitforHumanProstateSpecific,An...
(Date:11/25/2009)...TY,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc...ingpoint-of-carebloodanalysissystems,announcedtoda...r,willpresentatthe21stAnnualPiperJaffrayHealthCare...heconferencewillbeheldattheNewYorkPalaceHotelinNew...,manufacturesandmarketsportablebloodanalysissystem...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Treating Workers Mental Woes May Boost Productivity 56746 1Treating Workers Mental Woes May Boost Productivity 56746 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 1Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4
... GlaxoSmithKline (NYSE: GSK ),announced positive...d placebo-,controlled ITP Study with Eltrombopag),... adults with chronic immune (idiopathic) thrombocy... prior ITP therapies. Patients,receiving PROMACTA ... to,maintain platelet counts between 50,000 to 400...
...Bayer HealthCare Pharmaceuticals Inc. announced to...ine(R) (sargramostim) will be presented at the 50t...logy (ASH) from December 6-9, 2008 in San Francisc...m leading oncology and hematology research centers... presentations reporting important findings in leu...
Other Medicine Technology:GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 2GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 3GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 4GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 6GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 7GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 8Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 2Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 3Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 4Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 5Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 6
Large Solid Mallet
Hoke Chisel
Chisels
Lewin Bone Forceps
Medicine Products: